Treatment of migraine compound preparation sorority is stronger than single-drug treatment

Two recent trials conducted in the United Statesshowed that the naproxen/sumatriptan compound was more effective at treating migraines than using either drug aloneIn the two multicenter studies, the researchers analyzed drug efficacy data for 1441 (study 1) and 1470 (study 2) patientsThese patients received outpatient treatment for only one type of migraine and followed up for 1 to 5 days after treatmentPatients were randomly divided into four groups in a ratio of 1:1:1, and were treated with a single dose of psipurin/Shumuptan compound preparations of 500 mg/85 mg, psiproprical 500 mg, Shumuptan 85 mg or placeboThe patient can receive first aid treatment two hours after the treatment has been completedTwo hours after treatment, the use of fentanol/Shumapitan was significantly effective in reducing headaches (study 1,65 percent vs28 percent; study 2,57 percent vs29 percent), loss of light symptoms (study 1,58 percent vs36 percent; study 2,50 percent vs32 percent) and phobia (study 1,61 percent vs38 percent); study 2,56 percent to 34 percent)Compared to the placebo group, the rate of nausea symptoms disappeared significantly (71% vs65%) in the study 1 group after two hours of treatment (71% vs65%), and there was no significant difference between the two groups in study 2 (65% vs64%)In addition, the proportion of headache-free responses in the psiphon/Shumaptan group for 24 hours was significantly higher than in the study group (study 1,25% vs 16%) and the pupgengroup (study 1,25% vs 10%) and study 2,23% vs 10%) (Yang Minyan)